SODIUM BICARBONATE THERAPY IN METABOLIC ACIDOSIS WITH ACUTE KIDNEY INJURY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF MORTALITY AND RENAL OUTCOMES
Abstract
Introdução: Metabolic acidosis is common in critically ill patients and is associated with poor outcomes, particularly in those with advanced acute kidney injury (AKI). The 2021 Surviving Sepsis Campaign recommends sodium bicarbonate therapy in this setting based on post-hoc findings from the BICAR-ICU trial; however, BICAR-ICU 2 failed to demonstrate a mortality benefit, resulting in conflicting evidence. We conducted a systematic review and meta-analysis to evaluate the effects of bicarbonate therapy in this population. Objetivo: To evaluate whether sodium bicarbonate therapy improves mortality or renal outcomes in critically ill patients with metabolic acidosis and KDIGO stage II or III acute kidney injury (AKI). Método: We performed a systematic review and meta-analysis of randomized controlled trials and observational studies comparing sodium bicarbonate administration with standard care in adult critically ill patients. The primary outcome was short-term mortality (≤90 days), and the secondary outcome was the requirement for renal replacement therapy (RRT). Random-effects meta-analyses using restricted maximum likelihood estimation were conducted, and treatment effects were expressed as relative risks (RRs) with 95% confidence intervals (CIs). Certainty of evidence was assessed using the GRADE methodology. Resultados: Seven studies including 5,375 patients met the inclusion criteria. Sodium bicarbonate therapy was not associated with reduced mortality (RR 0.89, 95% CI 0.80–1.00; moderate certainty). In contrast, bicarbonate administration was associated with a lower need for RRT (RR 0.70, 95% CI 0.61–0.81; moderate certainty). Subgroup analyses showed no mortality benefit in randomized controlled trials or in patients with severe metabolic acidosis (pH ≤ 7.20). Conclusão: In critically ill patients with metabolic acidosis and KDIGO stage II or III AKI, sodium bicarbonate therapy was associated with a reduced need for RRT but not with improved survival. These findings support an individualized approach to bicarbonate administration and underscore the need for further high-quality randomized trials to better define its role in this population.